loader2
Partner With Us NRI

Company details

1,136.65
1,161.05
938.05
1,532.15
6M Return -14.95%
1Y Return 21.43%
Mkt Cap.(Cr) 9,200.42
Volume 898
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 898

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 863.73 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 23,827.16 -46,760.12
LAST 3M 69,266.52 -85,710.05
LAST 6M 140,902.25 -216,196.87
LAST 12M 235,226.83 -247,499.26
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
27.78
38.84%
173.3533
25.51%
23.33%
Description
  • Krishna Institute of Medical Sciences Limited was incorporated as `Jagjit Singh and Sons Private Limited`, a private limited company on July 26, 1973 at Mumbai. The Company changed the location of its registered office from the State of Maharashtra to the erstwhile State of Andhra Pradesh on February 21, 2003. Subsequently, the name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited` on January 2, 2004. Pursuant to the conversion of the Company to a public limited company, the name was changed to `Krishna Institute of Medical Sciences Limited` on January 29, 2004. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company. The Company is one of the leading multi-disciplinary integrated private healthcare services providers in southern India, operating a chain of multispecialty hospitals with focus on tertiary and quaternary healthcare. It has evolved as the largest corporate healthcare group in Andhra Pradesh and Telangana with network of six hospitals. The Company offers a comprehensive bouquet of healthcare services across specialties and super specialties through network of six hospitals under the "KIMS Hospitals" brand. The Company`s flagship hospital at Secunderabad is one of the largest private hospitals in India at a single location (excluding medical colleges), with a capacity of 1,000 beds. It has spread across six cities in the states of Andhra Pradesh and Telangana. Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 2,120 beds, including 1,705 operational beds. The Hospitals are equipped with state-of-the-art medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4-Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India ("NABH"). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories ("NABL"). The Hospital situated at Secunderabad was awarded the `Healthcare Excellence Award`, by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) ("AHPI") for nursing excellence, in 2015 and for `Patient Friendly Hospital`, in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016. In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, post-graduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board.

Read More

No Data Found

AGM Date (Month) :
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 543308
NSE Code : KIMS
Book Closure Date (Month) :
BSE Group : B
ISIN : INE967H01017

ICICIdirect Krishna Institute of Medical Sciences Ltd FAQ

You can buy Krishna Institute of Medical Sciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Krishna Institute of Medical Sciences Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 29, 2022 04:01 PM the closing price of Krishna Institute of Medical Sciences Ltd was ₹ 1,149.65.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 29, 2022 04:01 PM, the market cap of Krishna Institute of Medical Sciences Ltd stood at ₹ 9,200.42.
The latest PE ratio of Krishna Institute of Medical Sciences Ltd as of Jun 29, 2022 04:01 PM is 27.78
The latest PB ratio of Krishna Institute of Medical Sciences Ltd as of Jun 29, 2022 04:01 PM is 0.15
The 52-week high of Krishna Institute of Medical Sciences Ltd is ₹ 1,532.15 while the 52-week low is ₹ 938.05 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE